Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Novo Nordisk (GB:0QIU)

LSE:0QIU

0QIU

Novo Nordisk

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding GB:0QIU?

Track your performance easily

Link Broker

Novo Nordisk (0QIU) Income Statement

39 Followers

Novo Nordisk Income Statement

Last quarter (Q4 2023), Novo Nordisk's total revenue was kr65.86B, an increase of 59.61% from the same quarter last year. In Q4, Novo Nordisk's net income was kr21.96B. See Novo Nordisk’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	kr 212.89B	kr 232.26B	kr 176.95B	-	kr 126.95B	kr 122.02B
Cost of Revenue	kr 33.66B	kr 35.77B	kr 28.45B	-	kr 20.93B	kr 20.09B
Gross Profit	kr 179.23B	kr 196.50B	kr 148.51B	-	kr 106.01B	kr 101.93B
Operating Expense	kr 90.72B	kr 94.04B	kr 74.73B	-	kr 51.89B	kr 50.05B
Operating Income	kr 88.52B	kr 102.45B	kr 73.78B	-	kr 54.13B	kr 51.88B
Net Non Operating Interest Income Expense	kr -2.68B	kr 1.75B	kr -3.22B	-	kr -2.29B	kr -3.93B
Other Income Expense	kr -566.00M	kr -156.00M	kr -910.00M	-	-	-
Pretax Income	kr 86.70B	kr 104.67B	kr 68.58B	-	kr 52.98B	kr 48.55B
Tax Provision	kr 16.93B	kr 20.99B	kr 13.54B	-	kr 10.99B	kr 9.60B
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr 69.77B	kr 83.68B	kr 55.05B	-	kr 41.99B	kr 38.95B
Basic EPS	kr 22.09	kr 18.67	kr 12.26	kr 20.79	kr 18.05	kr 16.41
Diluted EPS	kr 22.02	kr 18.62	kr 12.22	kr 20.74	kr 18.01	kr 16.38
Basic Average Shares	kr 15.78B	kr 4.48B	kr 4.53B	kr 2.30K	kr 2.33K	-
Diluted Average Shares	kr 15.82B	kr 4.49B	kr 4.54B	kr 2.30K	kr 2.34K	-
Dividend Per Share	kr 8.15	-	kr 12.40	kr 10.40	kr 9.10	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 124.37B	kr 129.81B	kr 103.18B	-	-	-
Net Income From Continuing And Discontinued Operation	kr 69.77B	kr 83.68B	kr 55.05B	-	kr 41.99B	kr 38.95B
Normalized Income	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-

Currency in DKK

Novo Nordisk Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing